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Introduction
Torsades de pointes (TdPs) are polymorphic ventricular tachyarrhythmias which are commonly associated with prolongation of the QT interval of the electrocardiogram (ECG), and that may degenerate into ventricular fibrillation causing sudden death [1] [2] [3] . The prolongation of the QT interval of the ECG is associated with a reduction of cardiac ventricles repolarisation capacity [4, 5] . In the myocardium, several potassium currents contribute to the repolarisation and hence to the duration of action potential (AP) and QT interval [6] . When one of these repolarising currents is reduced, others may compensate this reduction. This is the concept of repolarisation reserve developed by several authors [4, 5, [7] [8] [9] . The delayed rectifier potassium current (I K ) is the most important repolarising current terminating the ventricular action potential in several species such as human, dog and guinea pig [4, 5, 7, 8, 10] . This current (I K ) results in two voltage and time dependent components: the rapidly activating current (I Kr ), and the slowly activating current (I Ks ) [11] [12] [13] [14] . The current carried by hERG channels corresponds to I Kr [15] whereas I Ks results from the coassembly of the subunits KCNQ1 and KCNE1 [16, 17] . Inhibition of I Kr or I Ks is implicated in the type 1 and 2 long QT syndrome (LQTS) which can be congenital [18, 19] or pharmacologically acquired [20, 21] . The pharmacological acquired form of the long QT syndrome results from the action of numerous cardiovascular and non-cardiovascular drugs that can reduce repolarisation capacity and cause prolongation of QT interval and TdPs [3] . Some of drugs responsible of TdPs in humans are able to inhibit I Kr . These drugs include many pharmacological classes such as antidepressants, neuroleptics, antihistamines and antimicrobials [9, [22] [23] [24] [25] [26] . On the opposite, only few drugs have been shown to inhibit specifically I Ks such as chromanol 293B, HMR1556 or L-735, 821 and the role of this current on the potential torsadogenic effect of new compound entities is probably underestimated in preclinical safety studies.
Although I Ks blockade alone induces only a small prolongation of action potential, recent studies have shown that the combination of I Ks and I Kr blockade markedly increases the incidence of TdPs, short-term QT interval variability and action potential prolongation [27] [28] [29] [30] . These results suggest that I Ks may play a significant protective role in limiting the occurrence of TdPs in the presence of I Ks blockers. Inhibition of I Ks and I Kr coupled with an activation of the late sodium persistent current I NaL has also been demonstrated to significantly increase the dispersion of repolarization, beat to beat variability (or instability) and the occurrence of TdPs in rabbits [31] . Nevertheless, the effects of combined pharmacological I Ks inhibition coupled with I NaL activation on prolongation and dispersion of cardiac repolarization has not yet been explored in the literature. Doxorubicin is an anticancer drug administrated during chemotherapeutic treatment of several tumours and haematological malignancies [32] . This compound has been reported to acutely prolong QT interval and to increase dispersion of repolarization [33] . Futhermore, we have recently shown that the QT prolongation observed in Guinea-pig isolated hearts in the presence of doxorubicin results from specific inhibition of I Ks [34] .
The purpose of the present work was to evaluate the consequences of the reduction of the repolarization reserve induced by specific I Ks inhibition on the prolongation and the dispersion of cardiac repolarization associated with I NaL activation. To this aim, we have investigated the effects of combined chromanol 293B (a specific I Ks blocker) [35, 36] and veratridine (an I NaL activator) [37] i) on the action potential duration and shape in Guinea pig papillary muscles and ii) on QT interval duration and dispersion of repolarisation in isolated Langendorff-perfused heart. We have also investigated the consequences of a reduction of the repolarization reserve by doxorubicin on the repolarization changes induced by veratridine. Effects of chromanol 293B (supplemental figure 1) were confirmed and effects of doxorubicin (previous work) were evaluated on I Ks current using HEK-293/KCNQ1-KCNE1 stable cell line.
Material and methods
All experimental procedures were performed in accordance with "The provision of the European Convention" on the protection of vertebrate animals which are used for experimental and other scientific purposes, and with "the Appendices A and B", made at Strasbourg on March 18, 1986 (Belgian Act of October 18, 1991) .
Cell culture and transfection
The coding sequences of hKCNQ1 and hKCNE1 genes were subcloned into pIRES-2-eGFP and pIRES-1-CD8 vectors respectively (Invitrogen, Cergy-pontoise, France). Both channel subunits were expressed in HEK-293 cells (American type culture collection, Manassas, VA, USA) by stable transfection process using Calcium Phosphate cationic method (ThermoFisher Scientific, France) with the protocole as described by the manufacturer. HEK-293 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) heat inactivated fetal bovine serum (FBS) and 1% (v/v) penicillin/ streptomycin in atmosphere 95% air / 5% CO 2 . HEK-293 cells were pricked out two times per week and seeded in T75 cm 3 flask to maintain cell culture and in 100 mm diameter Petri dishes to transfect cells at 300 000 cells per Petri dish density. 10 µg and 1 µg of pIRES-2-eGFP-KCNQ1 and pIRES-1-CD8-KCNE1 vectors respectively were used for the HEK-293 cells transfection. Then, first selection of transfected cells was performed using MACS (Magnetic Cell Sorting of Human leukocytes CD8 Microbeads, Miltenyi Biotec) specific kit as described by the manufacturer. Selected cells were grown in DMEM medium supplemented by 1mg/mL of Geneticin (G418, Sigma Aldrich) during one month with medium replacement every two days. Stable clones were isolated using cloning cylinders (Sigma Aldrich), and grown in DMEM meduim supplemented with 10% (v/v) heat inactivated fetal bovine serum (FBS), 1% (v/v) penicillin / streptomycin and 200 µg/mL of G418 in atmosphere 95% air / 5% CO 2 .
Electrophysiology
In order to observe cardiac Iks current inhibition by chromanol 293B on HEK-293/KCNQ1-KCNE1 stable cell line, electrophysiology experiments were performed using the patch perforated configuration with amphotericin B at 0.8 mg/mL into the pipette medium. Cells were seeded at a density 15000 cells / 35 mm dishes. Each current was calculated by using an axopatch 200B amplifier (Axon Instrument, Sunnyvale, CA, USA), low-pass filterd 3 kHz and digitized at 10 kHz using a 12-bits analog to digital converter digidata (1322 series, Axon Instrument, Sunnyvale, CA, USA). Patch clamp pipettes were pulled using vertical puller PC-10 (Narashighe, London, UK) from borosilicate glass capillaries with a resistance between 3-5 MΩ. The bath solution contained (in mM) 140 NaCl, 5.4 KCl, 1 MgCl 2 , 1.8 CaCl 2 , 0.3 NaH 2 PO 4 , 10 D-Glucose and 5 HEPES adjusted to pH 7.4 with NaOH. The pipette solution contained (in mM) 20 KCl, 110 K-Aspartate, 5 Na 2 -Phosphocreatine, 1 MgCl 2 , 5 EGTA and 10 HEPES and 0.8 mg/mL Ampho B adjusted to pH 7.2 with KOH. All experiments were performed at room temprature (22 °c). During patch recordings, cells were clamped at -80 mV and then depolarized from -70 mV to 100 mV during 3.5 sec by 10 mV increament steps following by 3.5 sec at -40 mV repolarising potential for each depolarization step to record tail current.
Pharmacological current inhibition by chromanol 293B was performed using a repetitive unique depolarization step at 100 mV from -80 mV during 3.5 sec following by 3.5 sec at -40 mV repolarising potential. In these protocols, the pulse cycling rate was 10 s and the current amplitudes were calculated at the pic of the tail current and the end of the first depolarization steps. Cells were continuously superfused with a microsuperfusion system. Current amplitudes were expressed in current densities. Results are expressed as mean ± standard error of the mean (SEM) from I Ks Itail amplitudes.
Guinea pig papillary muscle action potential recordings
The Guinea pig papillary muscles were prepared as follows. Guinea pigs (Darkin Hartley, Charles River laboratories) weighing between 370 and 460 g were anesthetized with intraperitoneal (i.p.) injection of sodium pentobarbital (90 mg/kg; CEVA Santé Animale, 54.7 mg/mL). In addition, heparin (250 IU, Choay) was also injected in i.p. A sternotomy followed by a pericardiotomy allowed the heart to be quickly removed and transferred to Tyrode's solution previously equilibrated for 20 minutes with a 95% O 2 -5% CO 2 gas mixture and containing (in mM): 113.10 NaCl, 21.90 NaHCO 3 , 1.81 NaH 2 PO 4 , 1.20 MgCl 2 , 2.45 CaCl 2 , 4.60 KCl, 5 Glucose, (pH 7.4 ± 0.5, adjusted with HCl or NaOH). The heart was removed from the wash solution and placed for dissection in Tyrode's solution and maintained at room temperature. Ventricles were isolated and papillary muscles were quickly removed from the right ventricle.
Papillary muscles were transferred in a Plexiglas tissue chamber and maintained by stainless steel minutiae pins. The preparation was then continuously superfused by the Tyrode's solution. This solution was gassed with 95% O 2 -5% CO 2 and flowed with a constant rate of 5 mL/min allowing a rapid renewal. Temperature in the Plexiglas tissue chamber was checked regularly during the experiment and maintained at +36.0 ± 0.5 °C. Preparation was stimulated at 1 Hz and superfused by the Tyrode's solution for about 45 minutes to allow stabilization before starting measurements. As soon as the contraction of the preparation was observed, the absence of spontaneous automatism was checked. When the preparation was stable, action potentials were recorded at 1 Hz. Intracellular electrical activity was recorded from cells on the surface of papillary muscles by means of microelectrodes (resistance ranged from 10 to 30 MΩ). These electrodes were drawn from borosilicate glass having an inner diameter of 1.16 mm and an outer diameter of 2.0 mm and containing an inner filament (GC200F-15, Phymep, France) filled with 2.7 M KCl. Microelectrodes were connected by an Ag/AgCl holder to a high-input impedance amplification system. The preparation was electrically stimulated through a bipolar Ag electrode with 2 ms-rectangular pulses and with an intensity of 1.5 times the threshold voltage to limit variations in latency between stimulus and action potential upstroke. Intracellular signals were displayed on a dual-beam oscilloscope, digitized at a basal sampling frequency of 32 kHz and amplified. These signals were analyzed with a microcomputer. An interactive software program (Acquis1, version 4.0) provided acquisition of data and on-line measurement of action potential parameters. An Ag electrode was used as a common reference. After the stabilization period, preparations were superfused with tyrode (prevalue), vehicle (baseline) and compounds (veratridine 1 µM, chromanol 293B 30 μM, doxorubicin 30 μM) using the experimental protocols described in figure   1A , n=6 for each group).
Isolated Langendorff-perfused Guinea pig hearts experiments
The isolated heart was prepared as follows. Guinea pigs (Darkin Hartley, Charles River laboratories) weighing between 400 and 570 g were anesthetized with intraperitoneal injection of sodium pentobarbital (90 mg/kg; CEVA Santé Animale, 54.7 mg/mL). In addition, heparin (250 IU, Choay) was also injected i.p. A sternotomy followed by a pericardiotomy allowed the heart to be quickly removed. Then, it was rinsed in Krebs-Henseleit solution at 4 °C and containing (in mM): 124.60 NaCl, 24.90 NaHCO 3 , 0.30 NaH 2 PO 4 , 1.10 MgSO 4 , 4.00 KCl, 11.10 Glucose, 2.00 Napyruvate, and 1.80 CaCl 2 (pH 7.4 ± 0.5, adjusted with HCl or NaOH). A perfusion cannula was inserted in the aorta for retrograde perfusion. Hearts were mounted in a thermostatic chamber and perfused at a pressure of 63 ± 3 mm Hg with a Krebs Henseleit solution. This solution was continuously warmed (37 ± 1 °C), buffered (pH 7.4 ± 0.05) and gassed with 95% O 2 -5% CO 2 . The perfusion pump (Minpulse 3, Gilson) was regulated by a pressure transducer coupled with an amplifier (MLT 0699, AD Instruments). A cannula with a fluid filled balloon was inserted in the left ventricle through the mitral orifice, and the balloon was connected to a pressure transducer coupled with an amplifier (BridgeAmp, AD Instruments) for monitoring left ventricular pressure and cardiac frequency. Hearts were allowed for a minimal 35 minutes stabilization period before recordings. Minimal diastolic pressure was adjusted to 10-15 mm Hg during the stabilization phase. The hearts were not electrically stimulated and followed their spontaneous rhythm. Two ECG electrodes connected to an ECG amplifier (Animal BioAmp, AD Instruments), were held lightly against the epicardium, one on the apex and the other on the right atria, to generate a bipolar electrocardiogram with well defined P waves, QRS complex, and T waves from which measurements of QT interval were done. ECG signals were digitized at 2 kHz and recorded on a PowerLab physiological data-acquisition system (PowerLab 8/30, AD Instruments). After the stabilization period, hearts were perfused with Krebs-Henseleit (prevalue), vehicle (baseline), and compounds (veratridine 300 nM, chromanol 293B 10 μM, doxorubicin 10 μM), alone during 10 minutes, in order to evaluate their 
Drugs
For all experiments, veratridine and chromanol 293B (Sigma-Aldrich), were prepared as stock solution in DMSO, and doxorubicin (Apin Chemical) was prepared as stock solution in distilled water. After dilution to the desired final concentrations, the DMSO and distilled water concentration was 0.1%. At this concentration, in the control experiments, DMSO and distilled water were shown to have no effects in both action potential and ECG parameters (data not shown).
Data analysis
In each experiment (action potential recordings and isolated perfused heart), values are expressed as mean and standard error of the mean (SEM), and percentage variations from baseline. 
Results

Effects on papillary muscle action potentials
Using experimental protocol described in Figure 1A , effects were evaluated on the following AP parameters, presented in the Table 1 : action potential duration at 40% (APD 40 ), 50% (APD 50 ), 70% (APD 70 ), 90% (APD 90 ), action potential triangulation (APD 90-40 ), resting potential (RP), action potential amplitude (Amplitude) and maximal upstroke velocity (dV/dt max ). The investigation of the effects of all drugs was mainly focused on two AP parameters, APD 90 and APD 90-40 since they constitute predictive factors of vulnerability to TdP occurrence [38] . potentiated the effects on APD 90 and on APD 90-40 (+114.0 ± 14.1 % and +429.9 ± 39.7 % respectively, p< 0.01 vs veratridine, Figure 1B ). In the other group, before doxorubicin addition, veratridine significantly increased APD 90 and APD 90-40 (+72.6 ± 7.0 % and +257.2 ± 32.6 %, respectively, p< 0.01 vs baseline, figure 1C) , as observed previously.
Doxorubicin superfused alone (20 min) did not significantly modify AP parameters (data not shown). Addition of doxorubicin significantly potentiated the effects of veratridine on APD 90 and on APD 90-40 (+104.7 ± 9.5 %, p< 0.001 and +382.2 ± 30.4 %, p< 0.01 respectively, vs veratridine, Figure 1C ). Effects on APD 90 and APD 90-40 by veratridine alone or combined to chromanol 293B or doxorubicin at 1 Hz stimulation rate are presented in Figure 2 A and B. In these groups, preparations were also stimulated at 0.5 Hz and veratridine alone showed reverse-frequency dependent effects on action potential duration and prolongation whereas the additional increase in APD 90 and APD 90-40 induced by the combination of veratridine and chromanol 293B or doxorubicin was not significantly different between the two stimulation rates (data not shown). The absence of reverse use dependence effects by doxorubicin and chromanol 293B addition to veratridine at low frequency confirm I Ks current involvement which is not affected by this process compare to IKr current. Effects of drugs on AP parameters are summarized in the Table 1 . 
Parameters
Effects on electrophysiological parameters on isolated perfused Guinea pig hearts
The effects of I Ks and I NaL channel modulators were investigated on the ECG parameters recorded on isolated perfused Guinea pig heart, and more particularly on the QT and T peak -T end (T p-e ) intervals. Since none of the evaluated drugs affect heart rate, QTc variations were similar to QT variations. T p-e interval, measured between the peak and the end of the T wave, corresponds to the transmural dispersion of cardiac repolarisation [39] [40] [41] . This interval is also expressed with the ratio T p-e / QT which is a better predictive indicator of TdPs vulnerability than QT and Tp-e considered independently [42] . interval statistical comparisons between the different groups were illustrated on the corresponding histogramms ( Figure   4 ).
Parameters RR interval (ms) PR interval (ms) QRS interval (ms) QT interval (ms)
As shown in the experimental protocol illustrated in Figure 3A , chromanol 293B or doxorubicin were tested for 5 min combined with veratridine, after 5 min pre-treatment with this last compound. Effects of drugs on ECG parameters are summarized in Table 2 . Typical traces of ECG recordings in control conditions and in the presence of veratridine alone or combined with chromanol 293B or doxorubicin, are shown in Figure 3B figure 4B ). Perfusion of chromanol 293B during 10 minutes induced a slight but significant increase in QT interval (+4.0 ± 0.8% and +5.0 ± 0.9% at 5 and 10 minutes respectively, p< 0.01 vs baseline, Figure 4A ) but did not statistically affect Tp-e interval ( Figures 4B) . Doxorubicin perfused during 10 minutes did not affect QT interval but induced a significant increase in Tp-e interval (+21.9 ± 6.2%, p< 0.01 vs baseline at 10 minutes, Figure 4B ). Figure 4B ). The analysis of the Tp-e/ QT ratio showed identical results as Tp-e interval effects (datas not shown).
I Ks current inhibition by chromanol 293B
In order to check cardiac I ks current inhibition by chromanol 293B on HEK-293/KCNQ1-KCNE1 stable cell line, electrophysiology experiments were performed using the patch perforated configuration with four drug concentrations 1, 3, 10 and 30 µM (Supplemental Figure 1) . Our data indicate that the cumulative perfusion of these chromanol 293B
concentrations has an inhibitory effect of I ks current with a significant decrease of its amplitude (Supplemental Figure   1A ). The current amplitude on the prepulse at + 100 mV potential decrease from 3. of function mutations in the congenital long QT syndrome (LQT1 or LQT5) where this current is involved [43, 44] .
This pharmacological inhibition results in drug side effects and could be evaluated in preclinical safety pharmacology test. Moreover, it has been shown that the cardiac I Ks potassium repolarizing current plays a key role in the ventricular repolarisation reserve process [4, 5] . In this context, first, we checked the I Ks current inhibition by chromanol 293B, a selective inhibitor and by doxorubicin, a chemotherapeutic molecule (previous published works [34] ), on HEK 293 cell line stably expressing KCNQ1 / KCNE1 subunits that constitute the channel responsible of I Ks potassium repolarizing current. Results on these previous works have demonstrated QT interval prolongation by I Ks inhibition without effects on I Kr repolarizing current showing the impotance of preclinical assessment on I Ks current inhibition. Then, in a second time, using these two inhibitors, we studied the role of the I Ks current in repolarisation reserve process on action potentials and ECG parameters using intracellular microelectrode in Guinea pig papillary muscle and Guinea pig isolated Langendorff perfused heart techniques.
In the pharmacological study, our data confirm that chromanol 293B inhibits I Ks current in a dose dependant manner.
The current amplitude is drastically decreased by the perfusion of cumulative concentrations of chromanol 293B with a partial reversible effect. The estimated IC 50 is 6.51 µM, a result close to those reported in the literature from several mamal species including human [35, 36] . Effects of doxorubicin were evaluated on I Ks current in previous published work [34] . The estimated IC 50 was 4.78 µM. Taken together, these data indicate that chromanol 293B and the chemotherapeutic agent doxorubicin could be used as inhibitors of I Ks current to study the role of this current in the repolarisation reserve process.
Then, we performed intracellular microelectrode and isolated Langendorff perfused heart experiments to study the role of I Ks ventricular repolarizing current in the repolarization reserve process. It has been shown that QT-interval prolongation itself is antiarrhythmic whereas it becomes proarrhythmic when it is associated with interrelated proarrhythmic factors including TRIaD (Triangulation Reverse use dependance Instability and Dispertion). These factors include action potential triangulation, reverse-use dependence, electrical instability of the action potential and dispersion of repolarization [45] [46] [47] . They are considered as biomarkers to predict the development of "torsade de pointes" arrhythmia.
In the present work, proarrhythmic conditions were induced by veratridine in both models. This alkaloid is known to activate a late persistent sodium current I NaL [37] which corresponds to incomplete or slowed I NaL inactivation [48] . As expected, veratridine (at 1 µM in action potential papillary muscle experiments and 300 nM in isolated perfused heart experiments) induced triangulation of the action potential associated to an increase of ADP 90-40 and a significant increase of action potential and QT interval duration. Furthermore, this agent showed reverse-frequency on action potential duration and caused a rise in dispersion of repolarisation (Tp-e interval, [49] ). The increase in AP-duration and reverse-use dependence have already been reported for veratridine in the same preparation [50] as well as in rabbit heart [31] . Both triangulation and dispersion were described on rabbit heart [51] . By contrast, chromanol 293B did not modify these parameters when tested alone. This result is in conformity with the experiment realized in dog, rabbit and human hearts [8, 10, 52] . It has also been reported that chromanol 293B did not increase the AP duration and triangulation in rabbit heart [27] . In the same way, we have tested the chemotherapeutic agent doxorubicin used to treat cancer. The present results indicate that the perfusion of this drug alone does not affect QT interval. This observation differ with our previous data recorded from the same preparation [34] and could be explained by differences in perfusion duration (10 min vs 45 min) and the concentrations used (10 µM vs 30 µM). As already reported in clinical pharmacological studies [33] , doxorubicin slightly amplified QT interval dispersion.
We also demonstrate here the participation of the slow outward potassium current in action potential triangulation and dispersion of repolarization induced after the activation of the sustained component of the fast sodium current. The block of I Ks by chromanol 293B in the presence of veratridine significantly increased action potential duration and triangulation and enhanced the index of dispersion of repolarization. Similar effects have been observed in the presence of doxorubicin under the same experimental conditions. As we previously showed, the chemotherapeutic agent doxorubicin blocks I Ks in isolated Guinea pig papillary muscle [34] . Taken together these data demonstrate the participation of the slow potassium current I Ks in the functional efficiency of repolarisation reserve. In situations where APD is prolonged, I Ks activation may limit excessive APD lengthening by a negative feedback mechanism providing more safety of the repolarisation process [5, 8] . It has been shown that I Ks is able to protect heart against the proarrhythmic reverse rate-dependent action potential triangulation induced by I Kr blockade [7, 27, 30] .
For the first time, we clearly show here that d oxorubicin at concentrations which do not modify the cardiac action potential duration, is able to reduce the repolarisation reserve probably by blocking the I Ks current. On the other hand, this work further confirms that I Ks limits the excessive prolongation of action potential and QT interval, and protects from the triangulation and dispersion processes caused by the late persistent sodium current. I NaL may be the consequence of pathological gating or regulation abnormalities such as LQT3 [53] , LQT4 [54] and LQT-CAV3 (LQT8) [55] syndromes. The sustained sodium current is also observed in acquired heart diseases as heart failure and post-infarction remodelled myocardium.
I NaL enhancement is generally associated with prolonged repolarisation and reduced repolarisation reserve [48] .
It can be concluded that the pharmacological block of I Ks does not prolong APD, but can decrease the safety of repolarisation reserve process and therefore increase the proarrhythmic risk, especially in the pathological situations where the late persistent sodium current is activated.
